 |
|
Ronald Scott, Chief Financial Officer, was born in 1955 and is a Swiss citizen. Mr.
Scott obtained undergraduate and graduate degrees in planning with
emphasis in finance. Prior to joining Basilea, he worked for nine years
at Roche in management positions in Pharmaceutical Finance, Licensing,
and the Roche Corporate Finance Mergers and Acquisitions group. His
assignments included managing Roche’s call, primary and secondary
offerings on Genentech; Roche’s biotechnology investment portfolio;
acquisitions and divestitures. Prior to joining Roche, Mr. Scott worked
for Prudential Investment Corporation in the United States as director
in Prudential’s Finance and International Business Development Units,
managing divestitures and joint venture transactions. |